Clinical Trial Update: FST-100 in the Treatment of Acute Adenoviral Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for FST-100 in acute adenoviral conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Conjunctivitis

Drugs mentioned

• FST-100

Snippet

Sponsor: Shire | Conditions: Acute Adenoviral Conjunctivitis | Phase 2 | Status: COMPLETED